No Data
US Stock MarketDetailed Quotes
ANVS Annovis Bio
Watchlist
9.410
-0.160-1.67% Close 09/27 16:00 ET
9.970High9.410Low23.42KVolume
9.610Open9.570Pre Close227.41KTurnover0.37%Turnover RatioLossP/E (TTM)84.81MMarket Cap23.88852wk HighLossP/E (Static)9.01MShares9.41052wk Low4.09P/B59.70MFloat Cap132.000Historical High--Dividend TTM6.34MShs Float2.418Historical Low--Div YieldTTM5.85%Amplitude9.708Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Annovis Bio Company
Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aims to treat neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
News
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
I Love Edgy Waifus : Thoughts on these @AmyNic ? Hopping in any? :o
jimmy the traderOP :
jimmy the traderOP I Love Edgy Waifus: Mimo wild